Importantly, our analysis using protein microarray technology and murine model of OAS will complement the traditional analysis of serum from patients with OAS/PFAS patients to clarify the molecular mechanisms of the syndrome caused by IgE cross-reactivity. This evidence concerns the gene IGHE and microphthalmia with limb anomalies.